drugset
drugset / Trial / NCT05065359

Multiple-Ascending Dose in Japanese Patients Bridging Study

NCT05065359 ↗

Phase 1 Completed 47 enrolled Altavant Sciences GmbH Parexel · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a randomized, placebo-controlled, multiple-ascending dose study in healthy Japanese and Caucasian subjects.

Timeline

Start
2021-10-01
Primary completion
2022-03-30
Completion
2022-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Rodatristat Ethyl Small molecule 300 mg Oral
Subject Rodatristat Ethyl Small molecule 600 mg Oral

Indications

No indication recorded.